Stryker preparing to sell $600 million offering of 10-year notes

By Devika Patel

Knoxville, Tenn., Feb. 26 – Stryker Corp. plans to sell $600 million of notes (Baa1) due 2028, according to a 424B5 filed with the Securities and Exchange Commission.

The notes feature a make-whole call until three months prior to maturity and then a par call.

Goldman Sachs & Co., Morgan Stanley & Co. LLC and Wells Fargo Securities LLC are the bookrunners.

Proceeds will be used to repay the company’s $600 million of 1.3% notes due April 1, 2018 at maturity.

Boston Scientific is a medical device maker based in Marlborough, Mass.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.